Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month

Email not displaying correctly? View it in your browser.
  Lab and Pathology Insider Logo  
July 10, 2018  
placeholder  ACQUISITIONS
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
From - Laboratory Industry Report
Mid-May to mid-June was the busiest period of the year for diagnostic deal making in terms of both volume and magnitude. Here is…
Read More
     

placeholder  COMPLIANCE
OIG Semiannual Report: Opioid Crackdown Is Making Labs a Prime Enforcement Target Once Again
From - G2 Compliance Advisor
Once the favorite whipping boy of federal enforcers, labs have been demanding less and less of the OIG's attention in recent years. But the newly published…
Read More
     


placeholder  GENETIC TESTING
Lack of Utility Evidence Still Hampers Adoption of Pharmacogenomic Testing: Benefits Seen in the Field of Psychiatry
From - Diagnostic Testing & Emerging Technologies
For years it had been hoped that pharmacogenetic (PGx) testing would be a leading application for personalized medicine…
Read More
     

placeholder  MACRA REQUIREMENT
How to Adjust to the April 2018 Medicare Beneficiary Cards
From - National Intelligence Report
In a press release on May 30, 2017, the Centers for Medicare & Medicaid Services (CMS) commented regarding their fraud prevention initiative program and their planned changes regarding…
Read More


 


For questions concerning delivery of this email, please contact customer service at:
(888) 729-2315 | customerservice@plainlanguagemedia.com

Copyright © 2018, All rights reserved.
Plain Language Media LLLP
PO Box 509, New London, CT 06320